Entity Wide Disclosures (Tables)

6 Months Ended

Jun. 30, 2022

Entity Wide Disclosures [Abstract]

Summary of Revenue by Major Source

The following table disaggregates our revenue by major source (in thousands):

	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2022		2021		2022		2021
Therapeutic Area
Oncology	$	115,542	$	93,248	$	220,755	$	172,386
Other		73,555		64,120		143,972		133,058
Metabolic		55,600		38,143		103,716		70,638
Cardiology		42,027		28,040		79,423		51,802
Central Nervous System		38,906		28,551		77,393		53,363
AVAI		25,577		26,191		56,895		57,011
Total revenue	$	351,207	$	278,293	$	682,154	$	538,258